AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹120 Cr | ₹800 Cr | ₹1,814 Cr | ₹-2,969 Cr | ₹-1,365 Cr |
What is the latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹120 Cr |
| Mar2024 | ₹800 Cr |
| Mar2023 | ₹1,814 Cr |
| Mar2022 | ₹-2,969 Cr |
| Mar2021 | ₹-1,365 Cr |
How is Cash Flow from Financing Activities of AUROBINDO PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹120 Cr | -85.04 | |
| Mar2024 | ₹800 Cr | -55.89 | |
| Mar2023 | ₹1,814 Cr | Positive | |
| Mar2022 | ₹-2,969 Cr | Negative | |
| Mar2021 | ₹-1,365 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹86,977.7 Cr | 1.3% | 10.9% | 28.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,735.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,312.0 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,369.0 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| CIPLA | ₹107,205.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,592.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 1.3% |
10.9% |
28.5% |
| SENSEX | -4.3% |
-2.6% |
-7.6% |
You may also like the below Video Courses